2014 Sep;155(9):3434-47
GLP-1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation. Obesity (Silver Spring, Md.), Sept
In response to growing criticism of the cost of their drugs, Novo Nordisk, the company that manufactures Ozempic and Wegovy, reported last year that rebates and other fees (across all payers) accounted for about 40% of the cost of the two drugs and that they expected rebates to grow
However, they are expensive, meaning everyone living with obesity may not have the chance to use them
In this blog, well explore: What Ozempic face really means The science behind GLP-1 medications How these drugs may affect mood and mental health Whats fact, whats mythand how to protect yourself Lets separate truth from TikTok
Lower doses usually work well only for maintaining the goal weight